现实世界 dostarlimab 在法国的晚期/复发性子宫内膜癌的使用
Manuel Rodrigues1, Lauriane Eberst2, Philippe Follana3
1Institut Curie, département d'oncologie médicale et Inserm U830, Paris, France.
Bulletin du cancer
|September 2, 2023
概括
作为一种编程死亡-1 抑制剂的多斯塔利马布 (Dostarlimab) 在法国实践中的子宫内膜癌患者中显示出有效性和安全性. 早期准入计划强调了对高级或复发病例的新疗法的需求.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 临床研究 临床研究
背景情况:
- 编程死亡-1 抑制剂Dostarlimab于2020年10月在法国获得了早期使用权.
- 它被批准用于不匹配修复缺陷/微卫星不稳定性高的先进/复发性子宫内膜癌的后治疗.
研究的目的:
- 通过临时授权对接受delarlimab的患者进行现实世界的描述性分析.
- 评估detaurlimab在这个患者群体中的安全性和有效性.
主要方法:
- 对获准暂时使用duralimab的患者进行描述性分析 (2020年11月 - 2021年6月).
- 通过医生随访表格和药监报告收集的数据.
- 包括临床信息,安全性和疗效数据.
主要成果:
- 80名患者至少接受了一剂detaurlimab.
- 疾病控制率为56% (24/43),整体应答率为35% (15/43).
- 没有发现新的安全信号.
结论:
- 80名患者的快速招生强调了法国对新型治疗的需求.
- 目前正在进行的研究将进一步评估dolarlimab和其他检查点抑制剂在子宫内膜癌.
更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.1K
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
14.7K
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
